510(k) device
Annalise Enterprise
Harrison-AI Medical Pty, Ltd. · Radiological Computer-Assisted Triage And Notification Software (QAS, Class II) · First FDA decision Mar 3, 2026, newest Mar 3, 2026Acute ischemic strokeBrain bleeding (hemorrhagic stroke)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
0
Naming "Annalise Enterprise"
MAUDE reports
0
Brand "Annalise Enterprise", since 2015
PubMed studies
0
Mentioning "Annalise Enterprise"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Annalise Enterprise
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Annalise EnterpriseBreakthrough510(k)
K253818 · Decided Mar 3, 2026 · 95 days after receipt
Device type: Radiological Computer-Assisted Triage And Notification Software (QAS) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Annalise Enterprise", any status and sponsor, newest update first.
No registered device study names "Annalise Enterprise".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Annalise Enterprise", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QAS
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Annalise Enterprise"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QAS.
- BriefCaseAidoc Medical , Ltd. · 510(k) 2022
- BriefCase-TriageAidoc Medical , Ltd. · 510(k) 2026
- Brainomix 360 Triage StrokeBrainomix Limited · 510(k) 2025
- Annalise Enterprise CTB Triage TraumaAnnalise-Ai Pty , Ltd. · 510(k) 2023
- Rapid ICH (v4.0)Ischemaview, Inc. · 510(k) 2026
- BriefCase-Triage: CARE Multi-Triage CT for PneumothoraxAidoc Medical , Ltd. · 510(k) 2026
- EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)Ever Fortune.Ai, Co., Ltd. · 510(k) 2024
- syngo.CT Brain HemorrhageSiemens Medical Solutions USA, Inc. · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.